Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for …
Over the last 12 months, insiders at Aethlon Medical, Inc. have bought $0 and sold $0 worth of Aethlon Medical, Inc. stock.
On average, over the past 5 years, insiders at Aethlon Medical, Inc. have bought $0 and sold $56,580 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
2020-12-17 | Sale | director | 26,852 0.2008% | $2.11 | $56,580 | +15.02% | ||
2010-04-13 | Sale | director | 9,800 0.015% | $0.34 | $3,283 | -26.47% | ||
2010-04-12 | Sale | director | 25,000 0.0383% | $0.34 | $8,375 | -26.47% | ||
2010-04-09 | Sale | director | 25,000 0.0381% | $0.33 | $8,338 | -26.47% | ||
2010-04-08 | Sale | director | 25,000 0.0383% | $0.34 | $8,375 | -26.47% | ||
2010-04-07 | Sale | director | 24,000 0.0395% | $0.35 | $8,400 | -24.24% | ||
2010-04-07 | Sale | director | 8,800 0.0145% | $0.35 | $3,080 | -24.24% | ||
2010-04-06 | Sale | director | 23,800 0.0359% | $0.35 | $8,330 | -30.56% | ||
2010-04-06 | Sale | director | 23,800 0.0359% | $0.35 | $8,330 | -30.56% | ||
2010-04-05 | Sale | director | 23,000 0.0348% | $0.35 | $8,073 | -30.56% | ||
2010-04-05 | Sale | director | 23,000 0.0348% | $0.35 | $8,073 | -30.56% | ||
2010-04-01 | Sale | director | 22,800 0.0354% | $0.37 | $8,436 | -32.43% | ||
2010-04-01 | Sale | director | 22,800 0.0354% | $0.37 | $8,436 | -32.43% | ||
2010-03-31 | Sale | director | 22,000 0.0328% | $0.36 | $8,030 | -34.21% | ||
2010-03-31 | Sale | director | 22,000 0.033% | $0.37 | $8,074 | -34.21% | ||
2010-03-30 | Sale | director | 22,000 0.041% | $0.38 | $8,360 | -30.56% | ||
2010-03-30 | Sale | director | 22,000 0.0404% | $0.37 | $8,239 | -30.56% | ||
2010-03-29 | Sale | director | 22,000 0.0384% | $0.39 | $8,470 | -35.90% | ||
2010-03-29 | Sale | director | 22,000 0.0377% | $0.38 | $8,327 | -35.90% | ||
2010-03-26 | Sale | director | 20,000 0.0362% | $0.41 | $8,200 | -37.50% |